The Laboratory of Infectious Disease Metabolomics is focused on characterizing amongst others; Human Immunodeficiency virus (HIV) and Mycobacterium tuberculosis (TB)-induced metabolic alterations, through the development and application of state of the art metabolomics technologies and/or approaches.

Considering the extremely high prevalence of these infections in Sub-Sahara Africa, and South Africa in particular, the laboratory is perfectly situated for addressing this problem, not only with regards to its location and collaborations with various local and international pathology laboratories, clinics and other collaborative infectious disease institutions, but also with regards to its research relevance towards curbing 3rd world and worldwide infectious diseases problems.